Nordic Life Science 1
THREE THINGS TO WATCH IN 2023 Digital therapeutic
s, the costs of gene and cell therapies, and a challenging financing situation were some of the hot topics in 2023 that SwedenBIO sniffed out at J.P. Morgan’s annual healthcare meeting in San Francisco. T E X T B Y M A R J O P U U M A L A I N E N 30 | NORDICLIFESCIENCE.ORG BUSINESS // COLUMN